Vital Signs - Benchtop Automation: Accelerating Bench to Bedside

Vital Signs - Benchtop Automation: Accelerating Bench to Bedside

 

RELEASE DATE
25-Apr-2011
REGION
North America
Research Code: 9561-00-C4-00-00
SKU: HC00623-NA-MR_04096
AvailableYesPDF Download
$1,500.00
In stock
SKU
HC00623-NA-MR_04096
$1,500.00
DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on April 25, 2011, provides analyts's summary of the American Association of Cancer Research (AACR) annual meeting.

Additionally, a company spotlight is provided for QuantaLife, a venture-backed startup company based in Pleasanton, Calif., developing third-generation of Polymerase Chain Reaction (PCR) technology that provides an absolute quantification measurement of target molecules in nanoliter droplet form. Reimbursement and regulatory news from the FDA is also provided for week of April 4, 2011.

Table of Contents

This week's issue

Related Research
This issue of Vital Signs, released on April 25, 2011, provides analyts's summary of the American Association of Cancer Research (AACR) annual meeting. Additionally, a company spotlight is provided for QuantaLife, a venture-backed startup company based in Pleasanton, Calif., developing third-generation of Polymerase Chain Reaction (PCR) technology that provides an absolute quantification measurement of target molecules in nanoliter droplet form. Reimbursement and regulatory news from the FDA is also provided for week of April 4, 2011.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9561-00-C4-00-00
Is Prebook No